Skip to main content
AARD logo

AARD

Aardvark Therapeutics, Inc.

$5.00

5.30%

Trade Ideas Performance

Latest Closed Trade Idea

$5.00

5.30%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

10

Social

38

About

Events of Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics' stock has been impacted by several events in the past six months. The company announced a voluntary pause of its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on February 27, 2026. Aardvark Therapeutics reported its fourth quarter and full year 2025 financial results on March 23, 2026, and its first quarter 2026 financial results and business updates on May 7, 2026. As of April 17, 2026, the stock price was $5.23, with a market capitalization of $109 million, and a 52-week range between $3.35 and $17.94.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Aardvark Therapeutics, Inc. (AARD) Live Stock Price, Chart & Financial News | Edge Hound